A kinetic model for phosphofructokinase based on the paradoxical action of effectors.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002951:Citrates / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D004163:Diphosphoglyceric Acids / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D005994:Glycerophosphates / Q000494:pharmacology; D007700:Kinetics; D009132:Muscles / Q000201:enzymology; D010710:Phosphates / Q000494:pharmacology; D010725:Phosphocreatine / Q000494:pharmacology; D010728:Phosphoenolpyruvate / Q000494:pharmacology; D010732:Phosphofructokinase-1 / Q000378:metabolism*; D011485:Protein Binding; D011817:Rabbits
D002951:Citrates; D004163:Diphosphoglyceric Acids; D005994:Glycerophosphates; D010710:Phosphates; D010725:Phosphocreatine; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D010728:Phosphoenolpyruvate; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D010732:Phosphofructokinase-1